Full weight-Based chemo doses recommended for obese

April 6, 2012
Full weight-Based chemo doses recommended for obese

(HealthDay) -- The American Society of Clinical Oncology Clinical Practice Guideline on Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer recommends using full weight-based cytotoxic chemotherapy doses to treat obese patients with cancer, according to an overview published online April 2 in the Journal of Clinical Oncology.

Jennifer J. Griggs, M.D., M.P.H., of the University of Michigan in Ann Arbor, and colleagues present a summary overview of the complete new guidelines. These recommendations, which do not address dosing of novel targeted agents, were developed by a panel of experts in medical and gynecologic oncology, , pharmacokinetics and pharmacogenetics, and biostatistics, after reviewing results from a systematic review of literature published between 1996 and 2010.

The researchers primarily identified studies relating to breast, ovarian, colon, and lung cancer. They note that up to 40 percent of obese patients receive limited chemotherapy doses, which are not based on their actual body weight. For obese patients, concerns about toxicity and overdosing when the dose is based on actual body weight appear to be unfounded.

"The Panel recommends that full weight-based cytotoxic chemotherapy doses be used to treat obese patients with cancer, particularly when the goal of treatment is cure. There is no evidence that short- or long-term toxicity is increased among obese patients receiving full weight-based doses," the authors write. "Clinicians should respond to all treatment-related toxicities in in the same ways they do for non-obese patients."

More information: Abstract
Full Text

Related Stories

Recommended for you

Strange circular DNA may offer new way to detect cancers

July 30, 2015

Strange rings of DNA that exist outside chromosomes are distinct to the cell types that mistakenly produced them, researchers have discovered. The finding raises the tantalizing possibility that the rings could be used as ...

New treatment options for a fatal leukemia

July 27, 2015

In industrialized countries like in Europe, acute lymphoblastic leukemia is the most common form of cancer in children. An international research consortium lead by pediatric oncologists from the Universities of Zurich and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.